Knockdown of Keap1 by siRNA in HNSCC cells demonstrated enhanced Nrf2 pathway activity, which led to enhanced transcriptional activity thereby rendering HNSCC cells resistant to chemotherapy. The gene discussed is NFE2L2; the disease is head and neck squamous cell carcinoma.